Total Thrombus formation Analysis System

 

 

 

 

mv01.jpg What’s T-TAST-TAS®︎ (Total Thrombus formation Analysis System) is an automated microchip flow chamber system developed for the quantitative assessment of the thrombus formation process under variable flow conditions. mv02.jpg ZACROS introductionWe re-shaped the inherited ZACROS concepts into the new “ZACROS GROUP CONCEPT” that consists of two parts; one is “ZACROS VISION” which represents where we are heading for, and the other part is “ZACROS ACTION” which describes how each of us should actually act in order to achieve “ZACROS VISION.”

img20220315115348924966.jpg What’s T-TAST-TAS®︎ (Total Thrombus formation Analysis System) is an automated microchip flow chamber system developed for the quantitative assessment of the thrombus formation process under variable flow conditions. img20220315115554403405.jpg ZACROS introductionWe re-shaped the inherited ZACROS concepts into the new “ZACROS GROUP CONCEPT” that consists of two parts; one is “ZACROS VISION” which represents where we are heading for, and the other part is “ZACROS ACTION” which describes how each of us should actually act in order to achieve “ZACROS VISION.”

NEWS RELEASE

VIEW ALL

[%article_date_notime%] [%new:New%][%category%]

[%title%]

 

PUBLICATIONS

 

A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions

The first paper on T-TAS system’s concept verification study.
T-TAS instrument and AR chip’s assay principle are explained.
リンク

A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process

T-TAS instrument and PL chip’s assay principle are explained.
It was suggested that T-TAS can distinguish the pharmacological effects of various antiplatelet drugs under physiological shear rates.
リンク

Total Thrombus-Formation Analysis System(T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease

The paper describes the role of T-TAS in cardiovascular disease.
The author concludes that T-TAS is a useful index for evaluating the total antithrombotic effects of combination antithrombotic agents in patients with various cardiovascular diseases.
リンク

A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia

The first paper on the T-TAS 01 HD assay.
The thrombogenic potential of thrombocytopenic patients before and after platelet transfusion was assessed with T-TAS HD assay.
HD assay results reflected the hemostatic function of patients with thrombocytopenita.
リンク

CATEGORIES

LITERATURE DATABASE

CONCEPT

Mission

Contribute to the worldwide development of medical treatment and the realization of a healthy society by developing and providing CHIGAI (differentiation) technologies, products and services.
  

Target

Create and expand our medical business as a new business pillar for Fujimori’s Next100.
 
 

Concept

Generate and expand our business in the targeted field by creating the “Only One” values (i.e., technology, products and services).